China’s Sinotau nets $152m to advance radiopharma pipeline ahead of IPO

Beijing Sinotau International Pharmaceutical Technology (Sinotau) has secured over 1.1 billion yuan ($151.8 million) in a new funding round to advance the R&D and clinical trials of its radiopharmaceutical pipeline…
Read More

About The Author

Jonathan Jeriah

See author's posts